vs
AST SpaceMobile, Inc.（ASTS）与Vericel Corp（VCEL）财务数据对比。点击上方公司名可切换其他公司
Vericel Corp的季度营收约是AST SpaceMobile, Inc.的1.7倍（$92.9M vs $54.3M），Vericel Corp净利率更高（25.0% vs -136.2%，领先161.2%），AST SpaceMobile, Inc.同比增速更快（2758.2% vs 23.3%），Vericel Corp自由现金流更多（$12.8M vs $-330.7M）
AST SpaceMobile是总部位于美国得克萨斯州米德兰的上市卫星设计与制造企业，目前正搭建SpaceMobile卫星星座，打造可直接对接未改装普通智能手机的天基蜂窝宽带网络，面向全球偏远及通信服务薄弱地区提供4G、5G宽带覆盖服务。
Vericel Corp是一家美国上市生物制药企业，前身为1989年在密歇根州安娜堡成立的Aastrom Bio，2014年10月正式更为现名，专注于生物制药相关领域的研发与商业化运营。
ASTS vs VCEL — 直观对比
营收规模更大
VCEL
是对方的1.7倍
$54.3M
营收增速更快
ASTS
高出2734.9%
23.3%
净利率更高
VCEL
高出161.2%
-136.2%
自由现金流更多
VCEL
多$343.6M
$-330.7M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $54.3M | $92.9M |
| 净利润 | $-74.0M | $23.2M |
| 毛利率 | — | 78.7% |
| 营业利润率 | -175.0% | 24.1% |
| 净利率 | -136.2% | 25.0% |
| 营收同比 | 2758.2% | 23.3% |
| 净利润同比 | -106.3% | 17.3% |
| 每股收益（稀释后） | — | $0.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTSVCEL
| Q4 25 | $54.3M | $92.9M | ||
| Q3 25 | $14.7M | $67.5M | ||
| Q2 25 | — | $63.2M | ||
| Q1 25 | — | $52.6M | ||
| Q4 24 | — | $75.4M | ||
| Q3 24 | — | $57.9M | ||
| Q2 24 | — | $52.7M | ||
| Q1 24 | — | $51.3M |
净利润ASTSVCEL
| Q4 25 | $-74.0M | $23.2M | ||
| Q3 25 | $-122.9M | $5.1M | ||
| Q2 25 | — | $-553.0K | ||
| Q1 25 | — | $-11.2M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | — | $-901.0K | ||
| Q2 24 | — | $-4.7M | ||
| Q1 24 | — | $-3.9M |
毛利率ASTSVCEL
| Q4 25 | — | 78.7% | ||
| Q3 25 | — | 73.5% | ||
| Q2 25 | — | 73.7% | ||
| Q1 25 | — | 69.0% | ||
| Q4 24 | — | 77.6% | ||
| Q3 24 | — | 71.9% | ||
| Q2 24 | — | 69.5% | ||
| Q1 24 | — | 68.9% |
营业利润率ASTSVCEL
| Q4 25 | -175.0% | 24.1% | ||
| Q3 25 | -1109.0% | 5.1% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -24.3% | ||
| Q4 24 | — | 24.5% | ||
| Q3 24 | — | -4.3% | ||
| Q2 24 | — | -11.5% | ||
| Q1 24 | — | -10.7% |
净利率ASTSVCEL
| Q4 25 | -136.2% | 25.0% | ||
| Q3 25 | -833.7% | 7.5% | ||
| Q2 25 | — | -0.9% | ||
| Q1 25 | — | -21.4% | ||
| Q4 24 | — | 26.3% | ||
| Q3 24 | — | -1.6% | ||
| Q2 24 | — | -8.9% | ||
| Q1 24 | — | -7.5% |
每股收益（稀释后）ASTSVCEL
| Q4 25 | — | $0.46 | ||
| Q3 25 | — | $0.10 | ||
| Q2 25 | — | $-0.01 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $-0.02 | ||
| Q2 24 | — | $-0.10 | ||
| Q1 24 | — | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3B | $137.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.4B | $354.6M |
| 总资产 | $5.0B | $488.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTSVCEL
| Q4 25 | $4.3B | $137.5M | ||
| Q3 25 | $2.4B | $135.4M | ||
| Q2 25 | — | $116.9M | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | — | $116.2M | ||
| Q3 24 | — | $101.7M | ||
| Q2 24 | — | $102.5M | ||
| Q1 24 | — | $110.6M |
股东权益ASTSVCEL
| Q4 25 | $2.4B | $354.6M | ||
| Q3 25 | $1.6B | $321.9M | ||
| Q2 25 | — | $306.8M | ||
| Q1 25 | — | $295.5M | ||
| Q4 24 | — | $292.0M | ||
| Q3 24 | — | $257.5M | ||
| Q2 24 | — | $243.0M | ||
| Q1 24 | — | $233.9M |
总资产ASTSVCEL
| Q4 25 | $5.0B | $488.0M | ||
| Q3 25 | $2.6B | $453.3M | ||
| Q2 25 | — | $435.6M | ||
| Q1 25 | — | $424.6M | ||
| Q4 24 | — | $432.7M | ||
| Q3 24 | — | $390.4M | ||
| Q2 24 | — | $376.8M | ||
| Q1 24 | — | $356.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $65.0M | $15.0M |
| 自由现金流经营现金流 - 资本支出 | $-330.7M | $12.8M |
| 自由现金流率自由现金流/营收 | -609.0% | 13.8% |
| 资本支出强度资本支出/营收 | 728.7% | 2.4% |
| 现金转化率经营现金流/净利润 | — | 0.65× |
| 过去12个月自由现金流最近4个季度 | $-790.4M | $24.7M |
8季度趋势，按日历期对齐
经营现金流ASTSVCEL
| Q4 25 | $65.0M | $15.0M | ||
| Q3 25 | $-64.5M | $22.1M | ||
| Q2 25 | — | $8.2M | ||
| Q1 25 | — | $6.6M | ||
| Q4 24 | — | $22.2M | ||
| Q3 24 | — | $10.2M | ||
| Q2 24 | — | $18.5M | ||
| Q1 24 | — | $7.2M |
自由现金流ASTSVCEL
| Q4 25 | $-330.7M | $12.8M | ||
| Q3 25 | $-302.9M | $19.5M | ||
| Q2 25 | — | $81.0K | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $-9.2M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | $-6.8M |
自由现金流率ASTSVCEL
| Q4 25 | -609.0% | 13.8% | ||
| Q3 25 | -2055.0% | 28.8% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | -14.5% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | -15.9% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | -13.3% |
资本支出强度ASTSVCEL
| Q4 25 | 728.7% | 2.4% | ||
| Q3 25 | 1617.6% | 3.9% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 27.0% | ||
| Q4 24 | — | 18.3% | ||
| Q3 24 | — | 33.5% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 27.3% |
现金转化率ASTSVCEL
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 4.35× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTS
| Products | $44.4M | 82% |
| Other | $7.8M | 14% |
| Sat Co | $2.1M | 4% |
VCEL
| MACI Implants And Kits | $84.1M | 90% |
| Other | $8.8M | 10% |
